crisis has brought the optimal design of pharmaceutical patent policy to the fore. In this paper we evaluate patent policy in … the US pharmaceutical industry. We estimate the effect of patent length and scope on generic entry prior to the expiration … of new drug patents using two quasi-experimental approaches: one based on changes in patent laws and another on the …

We analyze the effects on consumers of an extreme policy experiment -- Napsterizing' pharmaceuticals -- whereby all … patent rights on branded prescription drugs are eliminated for both existing and future prescription drugs without … compensation to the patent holders. The question of whether this policy maximizes consumer welfare cannot be resolved on an a …

We analyze the effects on consumers of an extreme policy experiment -- Napsterizing' pharmaceuticals -- whereby all … patent rights on branded prescription drugs are eliminated for both existing and future prescription drugs without … compensation to the patent holders. The question of whether this policy maximizes consumer welfare cannot be resolved on an a …

stage pharmaceutical innovation? We explore this question using novel data sources and an empirical framework that models … implications of our results for long-run welfare, policy, and innovation …

stage pharmaceutical innovation? We explore this question using novel data sources and an empirical framework that models … implications of our results for long-run welfare, policy, and innovation …